Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barton Duell

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Clinical Nutrition|August 24, 2004
Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetesGlenn T Gerhard, Andrew Ahmann, Kaatje Meeuws, et al.
American Journal of Preventive Cardiology|July 30, 2021
Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practiceBruce A Warden, Jonathan Q Purnell, P Barton Duell, et al.
Journal of Clinical Lipidology|September 1, 2016
Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemiaP Barton Duell, Raul D Santos, Bridget-Anne Kirwan, et al.
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
European Heart Journal|December 25, 2013
Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extensionRaul D Santos, P Barton Duell, Cara East, et al.
Current Atherosclerosis Reports|May 1, 2025
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in AdultsMaya S Safarova, Spencer Weintraub, Katherine Sadaniantz, et al.
JAMA Ophthalmology|September 20, 2019
Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral CataractsSharon F Freedman, Charlotte Brennand, John Chiang, et al.
Journal of Clinical Lipidology|April 18, 2024
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcoholsAndrea E DeBarber, Ernst J Schaefer, Jenny Do, et al.
American Journal of Preventive Cardiology|July 30, 2021
Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statementBruce A Warden, Johannes Steiner, Albert Camacho, et al.
American Journal of Preventive Cardiology|July 30, 2021
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocolBruce A Warden, Joshua R Miles, Carlota Oleaga, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Clinical Nutrition|August 24, 2004
Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetesGlenn T Gerhard, Andrew Ahmann, Kaatje Meeuws, et al.
American Journal of Preventive Cardiology|July 30, 2021
Real-world utilization of pharmacotherapy with new evidence-based cardiovascular indications in an academic preventive cardiology practiceBruce A Warden, Jonathan Q Purnell, P Barton Duell, et al.
Journal of Clinical Lipidology|September 1, 2016
Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemiaP Barton Duell, Raul D Santos, Bridget-Anne Kirwan, et al.
Journal of Clinical Lipidology|June 10, 2025
Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety dataMarcello Arca, Laura D'Erasmo, Marina Cuchel, et al.
European Heart Journal|December 25, 2013
Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extensionRaul D Santos, P Barton Duell, Cara East, et al.
Current Atherosclerosis Reports|May 1, 2025
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in AdultsMaya S Safarova, Spencer Weintraub, Katherine Sadaniantz, et al.
JAMA Ophthalmology|September 20, 2019
Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral CataractsSharon F Freedman, Charlotte Brennand, John Chiang, et al.
Journal of Clinical Lipidology|April 18, 2024
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcoholsAndrea E DeBarber, Ernst J Schaefer, Jenny Do, et al.
American Journal of Preventive Cardiology|July 30, 2021
Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statementBruce A Warden, Johannes Steiner, Albert Camacho, et al.
American Journal of Preventive Cardiology|July 30, 2021
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocolBruce A Warden, Joshua R Miles, Carlota Oleaga, et al.
Pageof 9